Why Is INTEGRA LIFESCIENCES (IART) Stock Moving Today?
INTEGRA LIFESCIENCES (IART) is drawing unusual attention today.
Integra Lifesciences shares fell 11.18% to $11.84 on October 21, 2026. The primary driver was a Q3 2026 earnings report where revenue missed estimates, compounded by ongoing supply disruptions at the company’s Cincinnati facility.
What Happened
Integra LifeSciences reported third-quarter 2026 adjusted earnings per share of $0.59, which beat the consensus estimate of $0.56. However, sales of $411.182 million fell short of the expected $414.120 million. The company attributed the revenue shortfall to a flooding event that disrupted operations at its Cincinnati facility. Management stated that this disruption is expected to extend into the second quarter of 2027.
Despite the operational strain, the company affirmed its full-year 2026 adjusted EPS guidance of $2.30 to $2.40 and sales guidance of $1.634 billion to $1.654 billion. For the fourth quarter, Integra projected adjusted EPS between $0.61 and $0.71 and sales between $413.000 million and $433.000 million. Both figures came in below analyst expectations. Kirby McInerney LLP announced that it is continuing an investigation into the company, inviting investors who lost money on IART investments to contact the firm.
What The Data Shows
The stock’s decline extends a broader downward trend, with the share price dropping 14.8% over the last eight sessions from $13.98 to $11.90. Integra currently trades within a 52-week range of $8.70 to $20.49. On the day of the earnings release, the stock printed 36 fresh 52-week lows. Fundamentals indicate a market capitalization of $1.0 billion with a beta of 1.21. The company remains unprofitable on a trailing twelve-month basis, with an EPS of -$0.10 and a net margin of -0.4%. Revenue growth over the same period was 1.6%.
What To Watch
Investors will monitor the company’s ability to mitigate the Cincinnati facility disruption as it extends into 2027. The coverage breadth includes 16 stories from six sources in the last 36 hours, highlighting the market’s focus on the balance between near-term strain and long-term resilience.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
IART by the numbers
The headlines behind the move
No wire coverage in the public window yet. Open the live terminal for the real-time tape.
More moves explained today
- Why is ACCV down today (-18.94%)
- Why is SVRA down today (-17.95%)
- Why is APLD down today (-17.45%)
- Why is AAOI down today (-16.14%)
- Why is CLS down today (-15.03%)
- Why is WOLF down today (-14.70%)
More on IART: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier IART move explainers: 2026-10-22 · 2026-10-05 · 2026-10-02